Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2
TAK-285（一种在研的EGFR和HER2抑制剂）的I期剂量递增、药代动力学和脑脊液分布研究
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-013-9988-x
LoRusso, Patricia; Venkatakrishnan, Karthik; Chiorean, E Gabriela; Noe, Dennis; Wu, Jing-Tao; Sankoh, Serap; Corvez, Maria; Sausville, Edward A
